VALPROL INJ contains sodium valproate, an anticonvulsant used in the management of epilepsy (seizure disorder), particularly when oral administration is not feasible.
It helps stabilize abnormal electrical activity in the brain, reducing the frequency and severity of seizures.
It is typically administered intravenously, particularly in hospital settings.
Not recommended for people with liver disease, porphyria, Alpers-Huttenlocher syndrome, or certain mitochondrial disorders.
VALPROL INJ should be used with caution in children, elderly patients, and those with kidney problems or urea cycle disorder.
Please complete your information below to login.
Sign In
Create New Account